Comparison of hepatitis C virus testing strategies: Birth cohort versus elevated alanine aminotransferase levels

American Journal of Preventive Medicine

Volumn 47, Issue 3, 2014, Pages 233-241

  Smith, Bryce D ^a   Yartel, Anthony K ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CDC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIRTH; BIRTH COHORT; BLOOD TRANSFUSION; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG USE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION SIZE; PREVALENCE; SENSITIVITY ANALYSIS; ALCOHOLIC BEVERAGE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEPATITIS C VIRUS; HIV TEST; MORBIDITY; MORTALITY; REVIEW; BLOOD; MIDDLE AGED; NUTRITION; SENSITIVITY AND SPECIFICITY; UNITED STATES; YOUNG ADULT;

ADULT; AGED; ALANINE TRANSAMINASE; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; SENSITIVITY AND SPECIFICITY; UNITED STATES; YOUNG ADULT;

EID: 84906307307     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.05.011     Document Type: Article

References (75)

1. G.L. Armstrong, A. Wasley, E.P. Simard, G.M. McQuillan, W.L. Kuhnert, and M.J. Alter The prevalence of hepatitis C virus infection in the U.S., 1999 through 2002 Ann Intern Med 144 10 2006 705 714
2. S.L. Chen, and T.R. Morgan The natural history of hepatitis C virus (HCV) infection Int J Med Sci 3 2 2006 47 52
3. G.L. Armstrong, M.J. Alter, G.M. McQuillan, and H.S. Margolis The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the U.S Hepatology 31 3 2000 777 782
4. M.J. Alter HCV routes of transmission: what goes around comes around Semin Liver Dis 31 4 2011 340 346
5. D.B. Rein, J.S. Wittenborn, C.M. Weinbaum, M. Sabin, B.D. Smith, and S.B. Lesesne Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the U.S Dig Liver Dis 43 1 2011 66 72
6. K.N. Ly, J. Xing, R.M. Klevens, R.B. Jiles, J.W. Ward, and S.D. Holmberg The increasing burden of mortality from viral hepatitis in the U.S. between 1999 and 2007 Ann Intern Med 156 4 2012 271 278
7. N. Hayashi, C. Seto, M. Kato, Y. Komada, and S. Goto Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1-infected patients in Japan: the DRAGON study J Gastroenterol 49 1 2014 138 147
8. E. Lawitz, A. Mangia, and D. Wyles et al. Sofosbuvir for previously untreated chronic hepatitis C infection N Engl J Med 368 20 2013 1878 1887
9. P.R. Spradling, L. Rupp, and A.C. Moorman et al. Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence Clin Infect Dis 55 8 2012 1047 1055
10. W.N. Southern, M.L. Drainoni, and B.D. Smith et al. Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting J Viral Hepat 18 7 2011 474 481
11. D.W. Roblin, B.D. Smith, C.M. Weinbaum, and M.E. Sabin HCV screening practices and prevalence in an MCO, 2000-2007 Am J Manag Care 17 8 2011 548 555
12. M.M. Denniston, R.M. Klevens, G.M. McQuillan, and R.B. Jiles Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: NHANES 2001-2008 Hepatology 55 6 2012 1652 1661
13. H. Hagan, J. Campbell, and H. Thiede et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors Public Health Rep 121 6 2006 710 719
14. Galbraith JW, Franco R, Rodgers J, et al. Screening in emergency department identifies a large cohort of unrecognized chronic hepatitis C virus. Paper presented at the 64th Annual Meeting of the American Association for the Study of Liver Diseases; 2013 Nov 1-5; Washington DC.
15. M.L. Drainoni, A.H. Litwin, and B.D. Smith et al. Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting Am J Public Health 102 11 2012 e115 e121
16. K.J. Tomaszewski, B. Deniz, P. Tomanovich, and C.S. Graham Comparison of current U.S. risk strategy to screen for hepatitis C virus with a hypothetical targeted birth cohort strategy Am J Public Health 102 11 2012 e101 e106
17. T.M. Shehab, S.S. Sonnad, and A.S. Lok Management of hepatitis C patients by primary care physicians in the USA: results of a national survey J Viral Hepat 8 5 2001 377 383
18. P.O. Coffin, A.M. Stevens, J.D. Scott, J.D. Stekler, and M.R. Golden Patient acceptance of universal screening for hepatitis C virus infection BMC Infect Dis 11 2011 160
19. J.B. Kallman, A. Arsalla, and V. Park et al. Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians Aliment Pharmacol Ther 29 9 2009 1019 1024
20. T.M. Shehab, M. Orrego, R. Chunduri, and A.S. Lok Identification and management of hepatitis C patients in primary care clinics Am J Gastroenterol 98 3 2003 639 644
21. E.C. Clark, B.P. Yawn, J.M. Galliher, J.L. Temte, and J. Hickner Hepatitis C identification and management by family physicians Fam Med 37 9 2005 644 649
22. E.A. Torrone, J.C. Thomas, and S. Maman et al. Risk behavior disclosure during HIV test counseling AIDS Patient Care STDS 24 9 2010 551 561
23. B.R. Edlin, T.F. Kresina, and D.B. Raymond et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users Clin Infect Dis 40 5S 2005 S276 S285
24. D. Swan, J. Long, and O. Carr et al. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration AIDS Patient Care STDS 24 12 2010 753 762
25. Batki S, Sorensen J. Care of injection drug users with HIV. In: Cohen PT, Sande MA, Volberding P, eds. The AIDS knowledge base: a textbook on HIV disease from the University of California, San Francisco and San Francisco General Hospital. 3rd ed. Philadelphia PA. Lippincott, Williams, & Wilkins, 1999.
26. S.F. O'Brien, G. Xi, Q.L. Yi, and M. Goldman Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use Transfus Med 20 1 2010 15 21
27. H.R. Rosen Clinical practice. Chronic hepatitis C infection N Engl J Med 364 25 2011 2429 2438
28. A.H. Litwin, B.D. Smith, and M.L. Drainoni et al. Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk Dig Liver Dis 44 6 2012 497 503
29. W.N. Southern, M.L. Drainoni, and B.D. Smith et al. Physician nonadherence with a hepatitis C screening program Qual Manag Health Care 23 1 2014 1 9
30. W.R. Kim, S.L. Flamm, A.M. Di Bisceglie, and H.C. Bodenheimer Public Policy Committee of the American Association for the Study of Liver Disease. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease Hepatology 47 4 2008 1363 1370
31. CDC Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease MMWR Recomm Rep 47 RR-19 1998 1 39
32. A.G. Coppola, P.C. Karakousis, and D.C. Metz et al. Hepatitis C knowledge among primary care residents: is our teaching adequate for the times? Am J Gastroenterol 99 9 2004 1720 1725
33. C. Helsper, G. van Essen, B.D. Frijling, and N.J. de Wit Follow-up of mild alanine aminotransferase elevation identifies hidden hepatitis C in primary care Br J Gen Pract 62 596 2012 e212 e216
34. C. Conry-Cantilena, M. VanRaden, and J. Gibble et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection N Engl J Med 334 26 1996 1691 1696
35. Rein DB, Wagner D, Brown K, et al. Hepatitis C antibody testing and follow-up in primary care settings: a retrospective study of four large, primary care service centers infection among persons born during 1945-1965 in the U.S. National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care; 2012 Nov 26-28; Washington DC.
36. D.S. Pratt, and M.M. Kaplan Evaluation of abnormal liver-enzyme results in asymptomatic patients N Engl J Med 342 17 2000 1266 1271
37. P. Sherwood, I. Lyburn, S. Brown, and S. Ryder How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact BMJ 322 7281 2001 276 278
38. D.T. Arnold, L.M. Bentham, R.P. Jacob, R.J. Lilford, and A.J. Girling Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort. BMC Fam Pract 12 2011 9
39. A. Dutta, C. Saha, C.S. Johnson, and N. Chalasani Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study Hepatology 50 6 2009 1957 1962
40. B.A. Neuschwander-Tetri, A. Unalp, and M.H. Creer Nonalcoholic Steatohepatitis Clinical Research Network. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels Arch Intern Med 168 6 2008 663 666
41. C.E. Ruhl, and J.E. Everhart Upper limits of normal for alanine aminotransferase activity in the U.S. population Hepatology 55 2 2012 447 454
42. S. Brillanti, M. Foli, S. Gaiani, C. Masci, M. Miglioli, and L. Barbara Persistent hepatitis C viraemia without liver disease Lancet 341 8843 1993 464 465
43. D.R. Dufour, J.A. Lott, F.S. Nolte, D.R. Gretch, R.S. Koff, and L.B. Seeff Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests Clin Chem 46 12 2000 2027 2049
44. J.K. Lee, J.H. Shim, and H.C. Lee et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology Hepatology 51 5 2010 1577 1583
45. D. Prati, E. Taioli, and A. Zanella et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann Intern Med 137 1 2002 1 10
46. M.H. Zheng, K.Q. Shi, and Y.C. Fan et al. Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population PLoS One 7 9 2012 e43736
47. A. Ahmed, and E.B. Keeffe Chronic hepatitis C with normal aminotransferase levels Gastroenterology 126 5 2004 1409 1415
48. B.D. Smith, R.L. Morgan, and G.A. Beckett et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 MMWR Recomm Rep 61 RR-4 2012 1 32
49. M.J. Alter, D. Kruszon-Moran, and O.V. Nainan et al. The prevalence of hepatitis C virus infection in the U.S., 1988 through 1994 N Engl J Med 341 8 1999 556 562
50. CDC. National Center for Health Statistics. NHANES Questionnaires, Datasets, and Related Documentation. cdc.gov/nchs/nhanes/nhanes-questionnaires. htm.
51. B.D. Smith, G.A. Beckett, A. Yartel, D. Holtzman, N. Patel, and J.W. Ward Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, U.S., 1999-2008 Am J Public Health 104 3 2014 474 481
52. C.E. Ruhl, and J.E. Everhart Diurnal variation in serum alanine aminotransferase activity in the U.S. population J Clin Gastroenterol 47 2 2013 165 173
53. CDC National Center for Health Statistics. NHANES laboratory protocol: biochemistry profile 1999-2000 USDHHS Hyattsville MD www.cdc.gov/nchs/data/ nhanes/nhanes-99-00/lab18-met-biochemistry-profile.pdf
54. CDC National Center for Health Statistics. NHANES 2001-2002 laboratory protocol: alanine amino transferase (ALT) in refrigerated serum 2001-2002 USDHHS Hyattsville MD www.cdc.gov/nchs/data/nhanes/nhanes-01-02/l40-b-met-alanine- amino-transferase.pdf
55. CDC National Center for Heaalth Statistics. NHANES public release data file: laboratory 40 - standard biochemistry profile, follicle stimulating hormone, and luteinizing hormone 2001-2002 USDHHS Hyattsville MD www.cdc.gov/nchs/data/nhanes/nhanes-01-02/l40-b-doc.pdf
56. CDC National Center for Health Statistics. NHANES laboratory protocol: alanine amino transferase (ALT) in refrigerated serum 2003-2004 USDHHS Hyattsville MD www.cdc.gov/nchs/data/nhanes/nhanes-03-04/l40-c-met-alanine- amino-transferase.pdf
57. CDC National Center for Health Statistics. NHANES laboratory protocol: alanine amino transferase (ALT) in refrigerated serum 2005-2006 USDHHS Hyattsville MD cdc.gov/nchs/data/nhanes/nhanes-05-06/biopro-d-met-alt.pdf
58. CDC National Center for Health Statistics. NHANES laboratory protocol: alanine amino transferase (ALT) in refrigerated serum 2007-2008 USDHHS Hyattsville MD www.cdc.gov/nchs/data/nhanes/nhanes-07-08/ALT-biopro-e-met- DXC800.pdf
59. CDC National Center for Health Statistics. NHANES analytic and reporting guidelines 2005 USDHHS Hyattsville MD www.cdc.gov/nchs/data/nhanes/nhanes-03-04/ nhanes-analytic-guidelines-dec-2005.pdf
60. CDC. National Center for Health Statistics. NHANES Response Rates and Population Totals. cdc.gov/nchs/nhanes/response-rates-cps.htm.
61. M.J. Alter Hepatitis C virus infection in the U.S. J Hepatol 31 1S 1999 S88 S91
62. C. Puoti HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy J Hepatol 38 4 2003 529 532
63. D. Prati, M.L. Shiffman, and M. Diago et al. Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C J Hepatol 44 4 2006 679 685
64. A. Alberti, F. Noventa, L. Benvegnu, S. Boccato, and A. Gatta Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection Ann Intern Med 137 12 2002 961 964
65. A. Alberti, L. Benvegnu, S. Boccato, A. Ferrari, and G. Sebastiani Natural history of initially mild chronic hepatitis C Dig Liver Dis 36 10 2004 646 654
66. R. Zapata Clinical approach to the patient with chronic hepatitis C infection and normal aminotransferases Ann Hepatol 9S 2010 S72 S79
67. D.B. Rein, B.D. Smith, and J.S. Wittenborn et al. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings Ann Intern Med 156 4 2012 263 270
68. P. McEwan, T. Ward, Y. Yuan, R. Kim, and G. L'Italien The impact of timing and prioritisation on the cost-effectiveness of birth-cohort testing and treatment for hepatitis C virus in the U.S J Hepatol 58 1 2013 54 64
69. L.J. McGarry, V.S. Pawar, and H.R. Panchmatia et al. Economic model of a birth cohort screening program for hepatitis C virus Hepatology 55 5 2012 1344 1355
70. R. Jamali, M. Khonsari, and S. Merat et al. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes World J Gastroenterol 14 18 2008 2867 2871
71. W. Sohn, D.W. Jun, and M.J. Kwak et al. The upper limit of normal of serum alanine and aspartate aminotransferase levels in Korea J Gastroenterol Hepatol 28 3 2013 522 529
72. U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. uspreventiveservicestaskforce.org/uspstf12/hepc/hepcfinalrs.htm.
73. American Association for the Study of Liver Diseases, Infectious Disease Society of America Recommendations for testing, managing,and treating hepatitis C 2014 American Association for the Study of Liver Diseases Alexandria VA www.hcvguidelines.org/sites/default/files/full-report.pdf
74. American College of Physicians. Screening for hepatitis C. smartmedicine.acponline.org/content.aspx?gbosId=496.
75. American Medical Association. AMA adopts new policies during first day of voting at interim meeting. ama-assn.org/ama/pub/news/news/2012-11-13-ama- adopts-new-policies.page.